The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 10, 2018

Filed:

May. 29, 2013
Applicant:

Korea Food Research Institute, Gyeonggi-do, KR;

Inventors:

Dong-Hwa Shon, Gyeonggi-do, KR;

Hee-Soon Shin, Gyeonggi-do, KR;

Min-Jung Bae, Gyeonggi-do, KR;

Ok-Hee Chai, Jeollabuk-do, KR;

Chang-Yuil Kang, Seoul, KR;

Dae-Woon Choi, Gangwon-do, KR;

Gye-Young Choi, Busan, KR;

Jeong-Hae Rho, Gyeonggi-do, KR;

Jeong-Ryong Do, Gyeonggi-do, KR;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A01N 65/00 (2009.01); A61K 36/00 (2006.01); A61K 36/73 (2006.01); A61K 36/708 (2006.01); A61K 36/84 (2006.01); A61K 36/39 (2006.01); A61K 36/482 (2006.01); A61K 36/738 (2006.01); A61K 36/185 (2006.01); A61K 36/49 (2006.01); A61K 36/47 (2006.01); A61K 36/532 (2006.01); A23L 33/105 (2016.01);
U.S. Cl.
CPC ...
A61K 36/708 (2013.01); A23L 33/105 (2016.08); A61K 36/185 (2013.01); A61K 36/39 (2013.01); A61K 36/47 (2013.01); A61K 36/482 (2013.01); A61K 36/49 (2013.01); A61K 36/532 (2013.01); A61K 36/738 (2013.01); A61K 36/84 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present invention provides a composition for preventing, improving, or treating Th1-mediated immune diseases or Th2-mediated immune diseases, an antihistamine composition, and an anti-inflammatory composition. The present invention provides a method for preventing, improving, or treating Th1-mediated immune diseases or Th2-mediated immune diseases, a method for inhibiting the release of histamine, and a method for preventing, improving, or treating inflammatory disorders. The composition according to the present invention has excellent inhibitory activities for IL-4 generation, the degranulation of mast cells, COX-2, 15-NOX, and the passing of allergens from through an intestinal epithelial cell layer, or an excellent Treg cell inducing activity. Further, the present invention provides a detailed mechanism of action of a natural substance and a food-drived antiallergenic substance, and provides stability, a reduction in production costs, and improved convenience of use by using a natural substance as a material.


Find Patent Forward Citations

Loading…